Scholarlink

Background <p>Data on ultrasound-guided vascular access (UGVA) to reduce vascular access complications in adult congenital heart disease (ACHD) patients undergoing catheter ablation (CA) on uninterrupted oral anticoagulation (OAC) are limited.</p> Objective <p>Comparison of UGVA to a standard approach with regard to vascular access complications in ACHD patients.</p> Methods <p>We retrospectively analyzed 477 consecutive ACHD patients (52% male, mean age 46 ± 14&#xa0;years) with simple (<i>n</i> = 166), moderate (<i>n</i> = 133), and complex (<i>n</i> = 178) congenital heart disease (CHD) who underwent 639 CA procedures for atrial tachycardia or fibrillation between 2014 and 2024. UGVA (243 patients, 271 ablations) was compared to a conventional approach (234 patients, 368 ablations) regarding vascular access complications under uninterrupted OAC (DOAC or VKA).</p> Results <p>Access was obtained via the femoral vein (<i>n</i> = 321), both femoral vein and artery (<i>n</i> = 311), or jugular vein with femoral artery (<i>n</i> = 7). UGVA significantly reduced overall vascular access complications compared to the standard approach (4.1% vs. 13.5%; <i>p</i> &lt; 0.001). Major complications occurred only in the conventional group (<i>n</i> = 4; AV fistula = 2, retroperitoneal hematoma = 2; <i>p</i> = 0.086). Minor complications—hematomas &gt; 5&#xa0;cm, small AV fistulas treated conservatively, or pseudoaneurysms treated by compression or ultrasound-guided thrombin injection—were also significantly lower with UGVA (4.1% vs. 12.5%; <i>p</i> &lt; 0.001).</p> Conclusions <p>UGVA significantly decreases vascular access complications in ACHD patients undergoing CA on uninterrupted OAC and may be advantageous for routine use in clinical practice.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ultrasound-guided femoral vascular access in adult congenital heart disease patients undergoing catheter ablation on uninterrupted oral anticoagulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月2日

查看全文
  • Marta Telishevska,
  • Sarah Lengauer,
  • Theresa Reiter,
  • Hannah Krafft,
  • Miruna Popa,
  • Fabian Bahlke,
  • Florian Englert,
  • Nico Erhard,
  • Isabel Deisenhofer,
  • Gabriele Hessling

摘要

Background

Data on ultrasound-guided vascular access (UGVA) to reduce vascular access complications in adult congenital heart disease (ACHD) patients undergoing catheter ablation (CA) on uninterrupted oral anticoagulation (OAC) are limited.

Objective

Comparison of UGVA to a standard approach with regard to vascular access complications in ACHD patients.

Methods

We retrospectively analyzed 477 consecutive ACHD patients (52% male, mean age 46 ± 14 years) with simple (n = 166), moderate (n = 133), and complex (n = 178) congenital heart disease (CHD) who underwent 639 CA procedures for atrial tachycardia or fibrillation between 2014 and 2024. UGVA (243 patients, 271 ablations) was compared to a conventional approach (234 patients, 368 ablations) regarding vascular access complications under uninterrupted OAC (DOAC or VKA).

Results

Access was obtained via the femoral vein (n = 321), both femoral vein and artery (n = 311), or jugular vein with femoral artery (n = 7). UGVA significantly reduced overall vascular access complications compared to the standard approach (4.1% vs. 13.5%; p < 0.001). Major complications occurred only in the conventional group (n = 4; AV fistula = 2, retroperitoneal hematoma = 2; p = 0.086). Minor complications—hematomas > 5 cm, small AV fistulas treated conservatively, or pseudoaneurysms treated by compression or ultrasound-guided thrombin injection—were also significantly lower with UGVA (4.1% vs. 12.5%; p < 0.001).

Conclusions

UGVA significantly decreases vascular access complications in ACHD patients undergoing CA on uninterrupted OAC and may be advantageous for routine use in clinical practice.

Graphical Abstract